Global Nattokinase Market Size To Worth USD 41.06 Million by 2033 | CAGR of 3.01%
Category: Consumer GoodsGlobal Nattokinase Market Size To Worth USD 41.06 Million by 2033
According to a research report published by Spherical Insights & Consulting, the Global Nattokinase Market Size is to Grow from USD 30.52 Million in 2023 to USD 41.06 Million by 2033, at a Compound Annual Growth Rate (CAGR) of 3.01% during the projected period.
Get more details on this report -
Browse key industry insights spread across 230 pages with 102 Market data tables and figures & charts from the report on the "Global Nattokinase Market Size, Share, and COVID-19 Impact Analysis, By Type (2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU), By Application (Nutraceuticals, Food Additives, Pharmaceuticals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/nattokinase-market
Nattokinase is an enzyme derived from natto. Natto, a fermented traditional soybean product, has been a staple of Japanese cuisine for decades. Nattokinase (NK) is produced by Bacillus subtilis bacteria during the fermentation of soybeans. Nattokinase is a potent protein that dissolves blood clots and is used to treat heart conditions. Natto is created by soaking and boiling soybeans, then fermenting them with Bacillus subtilis for up to 24 hours at 40°C. The natto is then cooled and matured in the refrigerator for up to a week, allowing stringiness to develop. The growing popularity of natural and functional supplements is another significant factor propelling the nattokinase market. The market is expected to grow due to the rising prevalence of cardiovascular conditions such as angina, deep vein thrombosis (DVT), high cholesterol, heart disease, stroke, and hypertension. Furthermore, the "blood thinner" action of nattokinase and bleeding problems that require extra care and caution are two of the main restrictive reasons. If blood pressure drops significantly, it may be an indication that the enzyme is having an adverse effect.
The 2,000 to 5,000 FU segment holds the highest market share of the nattokinase market during the projected timeframe.
Based on the type, the nattokinase market is divided into 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU. Among these, the 2,000 to 5,000 FU segment holds the highest market share of the nattokinase market during the projected timeframe. The market segment's substantial share in the worldwide business landscape may be ascribed to the safe range of nattokinase dose, which is between 100 and 200 mg daily. 2,000 to 5,000 FU are equivalent to these.
The nutraceuticals segment dominated the market with the largest revenue share of the nattokinase market during the projected timeframe.
Based on the application, the nattokinase market is divided into nutraceuticals, food additives, pharmaceuticals, and others. Among these, the nutraceuticals segment dominated the market with the largest revenue share of the nattokinase market during the projected timeframe. Growing awareness of their health and well-being, consumers are actively searching for effective and natural supplements that maintain their health. Nutraceuticals, or functional foods and dietary supplements, are considered safe and beneficial options.
Asia Pacific is expected to hold the largest share of the nattokinase market over the forecast period.
Get more details on this report -
Asia Pacific is expected to hold the largest share of the nattokinase market over the forecast period. China and Japan are two nations where nattokinase has been used traditionally for many centuries. Its historical and cultural use and acceptability are largely responsible for nattokinase's strong market position in these regions. Furthermore, there is a growing recognition in this area of the importance of cardiovascular health. Natto, a food made from fermented soybeans, has several nutritional benefits, including probiotics, vitamins, and minerals. Consumers are looking for simple yet wholesome food options as urban lifestyles get busier. This requirement is fulfilled by natto, which is available in ready-to-eat form.
North America is predicted to grow at the fastest pace in the nattokinase market during the projected timeframe. Consumers seeking more natural health supplements to improve their overall well-being are driving growth in the nattokinase industry. Due to the high prevalence of cardiovascular problems in the region, heart disease is the leading cause of mortality. The market for effective therapeutic and preventive solutions is driving the launch of nattokinase.
Major vendors in the nattokinase market are Japan Bio Science Laboratory Co., Ltd., Novonesis Group, Creative Enzymes, Weidan Biotechnology Co., Ltd., BIO-CAT, Bioven Ingredients, Eiffel Biotech, Daiwa Pharmaceutical Co. Ltd., Contek Life Science Co., Ltd., Sungen Bioscience Co., Ltd, Vedan Biotechnology, Toyo Hakko Co., Ltd., Belle Chemical, Hexon Laboratories Private Limited, and others.
Recent Developments
- In May 2021, Gnosis by Lesaffre, a well-known producer of vitamin K2, acquired NattoPharma to further enhance its offerings. Vitamin K2 is a vital component for bone and cardiovascular health, but the average modern diet does not contain enough of it. A few foods, including natto, are naturally high in vitamin K2, thus supplementation is required.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the nattokinase market based on the below-mentioned segments:
Global Nattokinase Market, By Type
- 2,000 to 5,000 FU
- 5,000 to 10,000 FU
- 10,000 to 15,000 FU
- 15,000 to 20,000 FU
Global Nattokinase Market, By Application
- Nutraceuticals
- Food Additives
- Pharmaceuticals
- Others
Global Nattokinase Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?